Off-resonance angiography: A new method to depict vessels-phantom and rabbit studies

Radiology

Volumn 249, Issue 2, 2008, Pages 501-509

  Korosoglou, Grigorios ^a   Shah, Saurabh ^a   Vonken, Evert Jan ^a   Gilson, Wesley D ^a   Schär, Michael ^a   Tang, Lijun ^a   Kraitchman, Dara L ^a   Boston, Raymond C ^b   Sosnovik, David E ^c   Weiss, Robert G ^a   Weissleder, Ralph ^c   Stuber, Matthias ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; MAGNETITE; NANOPARTICLE;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MAGNETIC RESONANCE ANGIOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SIGNAL NOISE RATIO; ANIMAL; IMAGE QUALITY; METHODOLOGY; REGRESSION ANALYSIS;

ANIMALS; CONTRAST MEDIA; FERROSOFERRIC OXIDE; MAGNETIC RESONANCE ANGIOGRAPHY; NANOPARTICLES; PHANTOMS, IMAGING; RABBITS; REGRESSION ANALYSIS;

EID: 56149083342     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2491071706     Document Type: Article

References (32)

1. Prince MR, Narasimham DL, Stanley JC, et al. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995;197:785-792.
2. Prince MR, Yucel EK, Kaufman JA, Harrison DC, Geller SC. Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography. J Magn Reson Imaging 1993;3:877-881.
3. Snidow JJ, Harris VJ, Trerotola SO, et al. Interpretations and treatment decisions based on MR angiography versus conventional arteriography in symptomatic lower extremity ischemia. J Vasc Interv Radiol 1995;6:595-603.
4. Tatli S, Lipton MJ, Davison BD, Skorstad RB, Yucel EK. From the RSNA refresher courses: MR imaging of aortic and peripheral vascular disease. Radio Graphics 2003;23(Spec Issue):S59-S78.
5. Yucel EK. MR angiography for evaluation of abdominal aortic aneurysm: has the time come? Radiology 1994;192:321-323.
6. Prince MR. Gadolinium-enhanced MR aortography. Radiology 1994;191:155-164.
7. Grist TM. Future directions of magnetic resonance angiography. Invest Radiol 1998;33:485-487.
8. Allkemper T, Heindel W, Kooijman H, Ebert W, Tombach B. Effect of field strengths on magnetic resonance angiography: comparison of an ultrasmall superparamagnetic iron oxide blood-pool contrast agent and gadopentetate dimeglumine in rabbits at 1.5 and 3.0 tesla. Invest Radiol 2006;41:97-104.
9. Clarke SE, Weinmann HJ, Dai E, Lucas AR, Rutt BK. Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits. Radiology 2000;214:787-794.
10. Allkemper T, Bremer C, Matuszewski L, Ebert W, Reimer P. Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits. Radiology 2002;223:432-438.
11. Frank H, Weissleder R, Brady TJ. Enhancement of MR angiography with iron oxide: preliminary studies in whole-blood phantom and in animals. AJR Am J Roentgenol 1994;162:209-213.
12. Mayo-Smith WW, Saini S, Slater G, Kaufman JA, Sharma P, Hahn PF. MR contrast material for vascular enhancement: value of superparamagnetic iron oxide. AJR Am J Roentgenol 1996;166:73-77.
13. Wang SC, Wikstrom MG, White DL, et al. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. Radiology 1990;175:483-488.
14. Bakker CJ, Seppenwoolde JH, Vincken KL. Dephased MRI. Magn Reson Med 2006;55:92-97.
15. Seppenwoolde JH, Viergever MA, Bakker CJ. Passive tracking exploiting local signal conservation: the white marker phenomenon. Magn Reson Med 2003;50:784-790.
16. Cunningham CH, Arai T, Yang PC, McConnell MV, Pauly JM, Conolly SM. Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med 2005;53:999-1005.
17. Edelman RR, Storey P, Dunkle E, et al. Gadolinium-enhanced off-resonance contrast angiography. Magn Reson Med 2007;57:475-484.
18. Stuber M, Gilson WD, Schar M, et al. Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON).Magn Reson Med 2007;58:1072-1077.
19. Shen T, Weissleder R, Papisov M, Bogdanov A Jr, Brady TJ. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med 1993;29:599-604.
20. Wunderbaldinger P, Josephson L, Weissleder R. Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug Chem 2002;13:264-268.
21. Choi SH, Han MH, Moon WK, et al. Cervical lymph node metastases: MR imaging of gadofluorine M and monocrystalline iron oxide nanoparticle-47 in a rabbit model of head and neck cancer. Radiology 2006;241:753-762.
22. Schar M, Kozerke S, Fischer SE, Boesiger P. Cardiac SSFP imaging at 3 Tesla. Magn Reson Med 2004;51:799-806.
23. Crawley AP, Henkelman RM. A comparison of one-shot and recovery methods in T1 imaging. Magn Reson Med 1988;7:23-34.
24. Fleckenstein JL, Archer BT, Barker BA, Vaughan JT, Parkey RW, Peshock RM. Fast short-tau inversion-recovery MR imaging. Radiology 1991;179:499-504.
25. Etienne A, Botnar RM, Van Muiswinkel AM, Boesiger P, Manning WJ, Stuber M. "Soapbubble" visualization and quantitative analysis of 3D coronary magnetic resonance angiograms. Magn Reson Med 2002;48:658-666.
26. Korosoglou G, Gilson WD, Schar M, et al. Hind limb ischemia in rabbit model: T2-prepared versus time-of-flight MR angiography at 3 T. Radiology 2007;245:761-769.
27. Anzai Y, Piccoli CW, Outwater EK, et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 2003;228:777-788.
28. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003;348:2491-2499.
29. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001;103:415-422.
30. Kooi ME, Cappendijk VC, Cleutjens KB, et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003;107:2453-2458.
31. Kodama T, Watanabe K. Influence of imaging parameters, flow velocity, and pulsatile flow on three-dimensional time-of-flight MR angiography: experimental studies. Eur J Radiol 1997;26:83-91.
32. Bourrinet P, Bengele HH, Bonnemain B, et al. Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest Radiol 2006;41:313-324.